Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.47 |
| ▸ | KLKB1 | P03952 | 3/20 | 0.46 |
| ▸ | ITGB1 | P05556 | 3/20 | 0.45 |
| ▸ | ITGA4 | P13612 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PLG | P00747 | 1/20 | 0.44 |
| ▸ | KLK1 | P06870 | 1/20 | 0.40 |
| ▸ | RARB | P10826 | 3/20 | 0.40 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15037355 | 1.00 | PPARG (0.47) | PPARGPPARAITGB3ITGA2BKLKB1 | |
| SCHEMBL22449153 | 0.94 | PPARG (0.49) | PPARGPPARAITGB3ITGA2BKLKB1 | |
| SCHEMBL15037352 | 0.94 | PPARG (0.49) | PPARGPPARAITGB3ITGA2BKLKB1 | |
| SCHEMBL15037341 | 0.92 | PPARG (0.49) | PPARGPPARAITGB3ITGA2BKLKB1 | |
| SCHEMBL22449059 | 0.92 | PPARG (0.49) | PPARGPPARAITGB3ITGA2BKLKB1 | |
| SCHEMBL15037347 | 0.92 | PPARG (0.49) | PPARGPPARAITGB3ITGA2BKLKB1 | |
| SCHEMBL15037075 | 0.91 | ITGB3 (0.47) | PPARGPPARAITGB3ITGA2BKLKB1 | |
| SCHEMBL22449136 | 0.91 | PPARG (0.49) | PPARGPPARAITGB3ITGA2BKLKB1 | |
| SCHEMBL15037343 | 0.91 | PPARG (0.49) | PPARGPPARAITGB3ITGA2BKLKB1 | |
| SCHEMBL15036988 | 0.91 | PPARG (0.49) | PPARGPPARAITGB3ITGA2BKLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2791112-B1 | CARBOXYLIC ACID DERIVATIVES COMPRISING FOUR CYCLES ACTING AS GLP-1 RECEPTOR MODULATORS FOR THERAPY OF DISEASES SUCH AS DIABETES | CELGENE INT II SÀRL (CH) | 2020-09-23 | — | — | EP | disclosed |